Abstract
In the past few years, an increasing number of in situ gel forming systems have been reported in the literature for various biomedical applications, including drug delivery, cell encapsulation, and tissue repair. The possible mechanisms that lead to in situ gel formation are solvent removal, ionic cross-linkage, light-sensitive, pH change and temperature modulation. The ability to inject a drug incorporated into a polymer to a localized site and have the drug from a semi-solid depot has a number of advantages. The advantages include ease of application, localized and prolonged drug delivery. For these reasons a large number of in situ setting polymeric delivery systems have been developed and investigated. This article reviews the stimuli-sensitive polymers and the use of these polymers in parenterals, ocular, peroral, rectal, vagina, nasal, dermal and transdermal drug delivery.
Keywords: In situ, gels, mucosa, drug delivery system, cell encapsulation, tissue repair, ionic cross-linkage, light-sensitive, semi-solid depot, stimuli-sensitive polymers
Current Drug Therapy
Title: In Situ Gels Based Drug Delivery Systems
Volume: 6 Issue: 3
Author(s): Madhugiri P. Venkatesh, Purohit K. Liladhar, Teggin M.P. Kumar and Hosakote G. Shivakumar
Affiliation:
Keywords: In situ, gels, mucosa, drug delivery system, cell encapsulation, tissue repair, ionic cross-linkage, light-sensitive, semi-solid depot, stimuli-sensitive polymers
Abstract: In the past few years, an increasing number of in situ gel forming systems have been reported in the literature for various biomedical applications, including drug delivery, cell encapsulation, and tissue repair. The possible mechanisms that lead to in situ gel formation are solvent removal, ionic cross-linkage, light-sensitive, pH change and temperature modulation. The ability to inject a drug incorporated into a polymer to a localized site and have the drug from a semi-solid depot has a number of advantages. The advantages include ease of application, localized and prolonged drug delivery. For these reasons a large number of in situ setting polymeric delivery systems have been developed and investigated. This article reviews the stimuli-sensitive polymers and the use of these polymers in parenterals, ocular, peroral, rectal, vagina, nasal, dermal and transdermal drug delivery.
Export Options
About this article
Cite this article as:
P. Venkatesh Madhugiri, K. Liladhar Purohit, M.P. Kumar Teggin and G. Shivakumar Hosakote, In Situ Gels Based Drug Delivery Systems, Current Drug Therapy 2011; 6 (3) . https://dx.doi.org/10.2174/157488511796392004
DOI https://dx.doi.org/10.2174/157488511796392004 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Central Nervous System Vasculitis: Still More Questions than Answers
Current Neuropharmacology Effects of Insulin on the Vasculature
Current Vascular Pharmacology Fluorescein Fluorescence Use in the Management of Intracranial Neoplastic and Vascular Lesions: A Review and Report of a New Technique
Current Drug Discovery Technologies Cerebral Vascular Aging: Extending the Concept of Pulse Wave Encephalopathy Through Capillaries to the Cerebral Veins
Current Aging Science Targeting Heme Oxygenase-1 in Vascular Disease
Current Drug Targets Neovascular Age-related Macular Degeneration: Past, Present, and Future
Current Angiogenesis (Discontinued) Recent Patents on Ocular Drug Delivery Systems
Recent Patents on Drug Delivery & Formulation Phytochemical Genistein in the Regulation of Vascular Function: New Insights
Current Medicinal Chemistry Nitric Oxide and Dietary Factors: Part V Summary/Conclusion and References
Vascular Disease Prevention (Discontinued) Novel and Emerging Targeted Therapies of Colorectal Cancer
Current Clinical Pharmacology Endothelin-1 Signaling in Vascular Physiology and Pathophysiology
Current Vascular Pharmacology Platelet Resistance to the Anti-Aggregating Agents in the Insulin Resistant States
Current Diabetes Reviews The Impact of Oxidative Stress on Islet Transplantation and Monitoring the Graft Survival by Non-Invasive Imaging
Current Medicinal Chemistry The Role of microRNAs in the Development of Type 2 Diabetes Complications
Current Pharmaceutical Design Current Protein-based Anti-angiogenic Therapeutics
Mini-Reviews in Medicinal Chemistry Vasoactive Factors and Diabetic Retinopathy: Vascular Endothelial Growth Factor, Cycoloxygenase-2 and Nitric Oxide
Current Pharmaceutical Design Disturbance of Inorganic Phosphate Metabolism in Diabetes Mellitus: Its Impact on the Development of Diabetic Late Complications
Current Diabetes Reviews Models for the Study of Angiogenesis
Current Pharmaceutical Design Peripartum Cardiomyopathy: Current State of Knowledge, New Developments and Future Directions
Current Cardiology Reviews Adiponectin and its Role in Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets